Cloud Banner

Healthcare

Image

Global Nano Bioreactor Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Feb 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Nano Bioreactor Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 8.5% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 3.28 Billion
Diagram Market Size (Forecast Year) USD 6.30 Billion
Diagram CAGR 8.5%

Global Nano Bioreactor Market, By Material (Glass, Stainless Steel, Single-Use), Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), Usage (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), Control Type (Manual, Automated (MFCs)), Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Nano Bioreactor Market Analysis and Size

Growing demand for personalized medicines will majorly impact the bioreactors industry dynamics. The increasing incidence of chronic diseases has led to a rise in awareness initiatives associated with recent developments in personalized medicines. The growth of bioreactors in pharmaceuticals, technological advancements in bioreactors, and increasing adoption of single-use bioreactors (SUBs) and hybrid bioreactors are the major factors responsible for the growth of the bioreactor market currently.  

Data Bridge Market Research analyses a growth rate in nano bioreactor market in the forecast period 2023-2030. The expected CAGR of nano bioreactor market tend to be around 8.50% in the mentioned forecast period. The market was valued at USD 3.28 billion in 2022, and it would grow upto USD 6.3 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Nano Bioreactor Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Material (Glass, Stainless Steel, Single-Use),Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), Usage (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), Control Type (Manual, Automated (MFCs)), Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Sartorius AG (Germany), Thermo Fisher Scientific (U.S.), General Electric (U.S.), Eppendorf AG (Germany), Merck KGaA (Germany), Pall Corporation (U.S.), ZETA (India), PIERRE GUERIN (France), PRaj Hipurity Systems Limited (India), Bioengineering AG (Switzerland), Infors AG (Switzerland), Solaris Biotechnology Srl. (Italy), Bbi Biotech (Germany), Bailun Biotechnology Co., Ltd. (China), PBS Biotech Inc. (U.S.), CerCell A/S (Denmark), GEA Group Aktiengesellschaft (Germany)

Market Opportunities

  • Growing Use of Hybrid Bioreactor Technology
  • Rising Adoption Of Single-Use Bioreactors Due To Growing Infections

Market Definition

Nano bioreactors are designed to make process development and small scale production of virus for vaccines or gene therapy easy and straightforward. These are vessels that have been designed and produced to offer an effective environment for enzymes or whole cells to transform biochemicals into products. In many of the cases, the inactivation of cells or sterilization is carried out in the bioreactor such as in water treatment.

Global Nano Bioreactor Market Dynamics

Drivers

  • Increasing Use of Recombinant Proteins

Recombinant proteins molecule is estimated to increase the growth of the market. Recombinant proteins have evolved as a prominent tool in medical research combined with promising effects against pathogen antigens. They are widely used as therapeutic proteins and replacement therapies, particularly in cases of hormonally active substances such as insulin and growth factor.  Thus, this factor increase the market growth.

  • Increasing Funding by Government Organizations

Growing investments in R&D activities leading to developing novel treatments for chronic ailments will boost the need for bioreactors at research firms. These initiatives are implemented globally to address the rising cases of diabetes, cancer, respiratory diseases, and cardiovascular disorders. Growing focus on drug development is anticipated to boost the demand for bioreactors at R&D organizations.

Opportunities

  • Rising Adoption Of Single-Use Bioreactors Due To Growing Infections

Single-use bioreactors are widely used in R&D and the production of novel vaccines. With the development of new infectious diseases such as COVID-19, numerous pharma companies have increased the adoption of these technologies. Numerous end-users are converting to single-use products because of advantages such as flexible process flow, cost-effectiveness, and lower cost of the material. Numerous advancements in miniaturized single-use bioreactors are further allowing R&D organizations to assuring cost efficiency. Thus, this factor significantly increases the market growth.

  • Growing Use of Hybrid Bioreactor Technology

The wide use of hybrid bioreactor technology in effective waste management has increased the expansion of the market. Several initiatives by major market players are also boosting the market growth. For instance, Beckman Coulter Life Sciences launched its next-generation Biolector XT Microbioreactor in Germany in May 2021. The BioLector XT Microbioreactor enables high-throughput strain screenings, cultivation parameter monitoring, and feeding strategy optimization.​ Thus, this increasing expenditure will increase the growth rate.

 Restraints/Challenges

  • Limited Space of Bioreactors  

The biggest disadvantage of nanobioreactors lies in its scaling. Large, flat rocker bioreactors do not scale well. They usually vary from only 5 to 100 L, with their size restricted by the rate of oxygen transfer through the headspace. Thus, this restraint hinders the usage of nanobioreactors by market players and organizations.

This nano bioreactor market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nano bioreactor market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In 2022, Getinge AB announced that their bioreactors will support the Dutch government's initiative to manufacture animal products such as meat and milk proteins directly from animal and microbial cells.

Global Nano Bioreactor Market Scope

The nano bioreactor market is segmented on the basis of material, cell, usage, molecule, control type, technology and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Material

  • Glass
  • Stainless Steel
  • Single-Use

Cell

  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells

Usage

  • Lab-Scale Production
  • Pilot-Scale Production
  • Full-Scale Production

Molecule

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Stem Cells
  • Gene Therapy

Control Type

  • Manual
  • Automated (MFCs)

Technology

  • Wave-Induced Motion SUB
  • Stirred SUB
  • Single-Use Bubble Column

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Nano Bioreactor Market Regional Analysis/Insights

The nano bioreactor market is analyzed and market size insights and trends are provided by material, cell, usage, molecule, control type, technology and end-user as referenced above.

The major countries covered in the nano bioreactor market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for nano bioreactor market throughout the forecast period because of the numerous strategies, such as mergers and acquisitions research and development and product launches. Furthermore, the increasing demand for biopharmaceutical products in the region and the focus on increasing localized production are anticipated to have a major impact on the market during the forecast period.

North America dominates the market due to the increase in collaboration among the industry and academic institutions. The U.S. holds the majority of the market in the North American region as pharmaceuticals and other hi-tech product makers have announced multimillion-dollar investments to expand manufacturing capabilities.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Nano Bioreactor Market Share Analysis

The nano bioreactor market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related nano bioreactor market.

Key players operating in the nano bioreactor market include:

  • Sartorius AG (Germany)
  • Thermo Fisher Scientific (U.S.)
  • General Electric (U.S.)
  • Eppendorf AG (Germany)
  • Merck KGaA (Germany)
  • Pall Corporation (U.S.)
  • ZETA (India)
  • PIERRE GUERIN (France)
  • PRaj Hipurity Systems Limited (India)
  • Bioengineering AG (Switzerland)
  • Infors AG (Switzerland)
  • Solaris Biotechnology Srl. (Italy)
  • Bbi Biotech (Germany)
  • Bailun Biotechnology Co., Ltd. (China)
  • PBS Biotech Inc. (U.S.)
  • CerCell A/S (Denmark)
  • GEA Group Aktiengesellschaft (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Nano Bioreactor Market is projected to grow at a CAGR of 8.50% during the forecast period by 2030.
The future market value of the Nano Bioreactor Market is expected to reach USD 6.3 billion by 2030.
The major players in the Nano Bioreactor Market are Sartorius AG (Germany), Thermo Fisher Scientific (U.S.), General Electric (U.S.), Eppendorf AG (Germany), Merck KGaA (Germany), Pall Corporation (U.S.), ZETA (India), PIERRE GUERIN (France), etc.
The countries covered in the Nano Bioreactor Market are U.S., Canada, Mexico, Germany, U.K., France, Italy, Russia, Switzerland, Spain, Belgium, Turkey, Denmark, Sweden, Poland, Netherlands, Rest of Europe, China, Japan, India, Taiwan, Singapore, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials